Statistics
Publications
7
Citations
213
H-Index
7
Active since
1985
Seth‐Olov Thorberg is an author at Karolinska Institutet specializing in medicine, pharmacology, and neuropharmacology.
Publications per year
1985–2002
7
7
Robalzotan (NAD‐299), a Novel Selective 5‐HT<sub>1A</sub>Receptor Antagonist
Svante B. Ross, Seth‐Olov Thorberg, Eva Jerning et al. · CNS Drug Reviews · 1999 · 30 citations · Full text
1–5 of 7